Affiliation:
1. World Federation of Hemophilia Montreal Quebec Canada
2. National Bleeding Disorders Foundation New York USA
3. Association Française des Hémophiles Paris France
4. Cliniques Universitaires Saint‐Luc Brussels Belgium
5. South African Haemophilia Foundation Johannesburg South Africa
6. Unidad y Desarrollo Hermanos con Hemofilia Guadalajara Mexico
7. National Hemophilia Foundation of Thailand Bangkok Thailand
Abstract
AbstractIntroductionInherited bleeding disorders (IBD) are genetic conditions that affect blood clotting, leading to complications such as prolonged or spontaneous bleeding into muscles or joints. Early identification and treatment are crucial to prevent complications and improve outcomes. However, effective patient outreach and identification programs for IBD face significant challenges globally.AimThis study aimed to identify successful patient outreach initiatives for IBD, barriers encountered during implementation, and approaches used to overcome them.MethodsThe World Federation of Haemophilia (WFH) conducted a survey of its national member organizations and other patient associations, totalling 153 organizations, to identify common strategies, barriers to their implementation, and solutions for outreach and the identification of people with IBD. The survey consisted of both closed‐ended and open‐ended questions, and the data were analysed using descriptive statistics and thematic analysis.ResultsCommon challenges included resource and sustainability‐related aspects such as financial constraints, limited lab equipment for diagnosis, and inadequate government commitment. Significant barriers also encompassed physical/geographical challenges like difficulty accessing remote areas, and inadequate logistical support and transportation. Seven themes emerged to enhance patient outreach: resource mobilization; awareness‐raising and advocacy; knowledge and capacity building; collaboration and partnership; decentralization of services; improved logistical support and infrastructure; utilization of technology and innovation; and financial aid and incentives.ConclusionMultistakeholder collaboration, coupled with secured government commitment, is crucial for improving global outreach, diagnosis rates, and access to care for individuals with IBD. Customized outreach programs should consider regional contexts, financial constraints, and prioritize innovation.
Subject
Genetics (clinical),Hematology,General Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献